Joël S. Bloch

762 total citations
18 papers, 531 citations indexed

About

Joël S. Bloch is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Joël S. Bloch has authored 18 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Joël S. Bloch's work include Glycosylation and Glycoproteins Research (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and MRI in cancer diagnosis (2 papers). Joël S. Bloch is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and MRI in cancer diagnosis (2 papers). Joël S. Bloch collaborates with scholars based in Switzerland, United States and France. Joël S. Bloch's co-authors include Kaspar P. Locher, Judith Michels, Marie Sébert, Jean‐Philippe Spano, David Khayat, Roger Mouawad, Michael Sixt, Maximilian Nitschké, Cornelia Halin and Anthony A. Kossiakoff and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Joël S. Bloch

18 papers receiving 527 citations

Peers

Countries citing papers authored by Joël S. Bloch

Since Specialization

Citations

This map shows the geographic impact of Joël S. Bloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël S. Bloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël S. Bloch more than expected).

Fields of papers citing papers by Joël S. Bloch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël S. Bloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël S. Bloch. The network helps show where Joël S. Bloch may publish in the future.

Co-authorship network of co-authors of Joël S. Bloch

This figure shows the co-authorship network connecting the top 25 collaborators of Joël S. Bloch. A scholar is included among the top collaborators of Joël S. Bloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël S. Bloch. Joël S. Bloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Structure, sequon recognition and mechanism of tryptophan C-mannosyltransferase 2023 ·Nature Chemical Biology ·Joël S. Bloch, Alan John, Runyu Mao, Somnath Mukherjee, Jérémy Boilevin, Rossitza N. Irobalieva, Tamis Darbre, Nichollas E. Scott, Jean‐Louis Reymond, Anthony A. Kossiakoff, Ethan D. Goddard‐Borger, Kaspar P. Locher	20
2	Molecular basis for glycan recognition and reaction priming of eukaryotic oligosaccharyltransferase 2022 ·Nature Communications ·Ana S. Ramίrez, (unknown), (unknown), Julia Kowal, Joël S. Bloch, Rossitza N. Irobalieva, Jean‐Louis Reymond, Markus Aebi, Kaspar P. Locher	18
3	Generation of nanobodies targeting the human, transcobalamin‐mediated vitamin B ₁₂ uptake route 2022 ·The FASEB Journal ·Joël S. Bloch, Jeffrey M. Sequeira, Ana S. Ramίrez, Edward V. Quadros, Kaspar P. Locher	2
4	Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins 2021 ·Proceedings of the National Academy of Sciences ·Joël S. Bloch, Somnath Mukherjee, Julia Kowal, E.V. Filippova, Martina Niederer, Els Pardon, Jan Steyaert, Anthony A. Kossiakoff, Kaspar P. Locher	58
5	Contribution of Oxyanion Stabilization to Kemp Eliminase Efficiency 2020 ·ACS Catalysis ·Hajo Kries, Joël S. Bloch, H. Adrian Bunzel, Daniel M. Pinkas, Donald Hilvert	19
6	Structure and mechanism of the ER-based glucosyltransferase ALG6 2020 ·Nature ·Joël S. Bloch, (unknown), Jérémy Boilevin, Kamil Nosol, Rossitza N. Irobalieva, Tamis Darbre, Markus Aebi, Anthony A. Kossiakoff, Jean‐Louis Reymond, Kaspar P. Locher	54
7	Exploring Local Diffusion MRI Properties for Vim Localization: Evaluation in Clinical Cases 2017 ·Journal of Neurological Surgery Part A Central European Neurosurgery ·Elena Najdenovska, Constantin Tuleasca, Joël S. Bloch, P. Maeder, Nadine Girard, Tatiana Witjas, Jean Régis, Jean‐Philippe Thiran, Meritxell Bach Cuadra, Marc Levivier	2
8	Structure of the human transcobalamin beta domain in four distinct states 2017 ·PLoS ONE ·Joël S. Bloch, Markus Ruetz, Bernhard Kräutler, Kaspar P. Locher	4
9	Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic Vessels 2016 ·Cell Reports ·Erica Russo, Álvaro Teijeira, Kari Vaahtomeri, (unknown), Joël S. Bloch, Maximilian Nitschké, Laura Santambrogio, Dontscho Kerjaschki, Michael Sixt, Cornelia Halin	144
10	Structural basis of transcobalamin recognition by human CD320 receptor 2016 ·Nature Communications ·Amer Alam, Jae‐Sung Woo, Jennifer Schmitz, (unknown), Katharina Root, Fan Chen, Joël S. Bloch, Renato Zenobi, Kaspar P. Locher	42
11	Author identification using Sequential Minimal Optimization 2016 ·John Jenkins, (unknown), Kaushik Roy, Albert Esterline, Joël S. Bloch	6
12	Treatment for metastatic malignant melanoma: Old drugs and new strategies 2009 ·Critical Reviews in Oncology/Hematology ·Roger Mouawad, Marie Sébert, Judith Michels, Joël S. Bloch, Jean‐Philippe Spano, David Khayat	94
13	Validation of the selected dose of aflibercept (VEGF Trap) plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in a phase I clinical trial of patients (pts) with advanced solid tumors (STs): Preliminary results 2008 ·Journal of Clinical Oncology ·Chris Verslype, Jean-Philippe Spano, Eric Van Cutsem, (unknown), Vincent Vandecaveye, Joël S. Bloch, (unknown), Sylvie Assadourian, Sabine Tejpar, D. Khayat	8
14	CT perfusion as index of activity of antiangiogenic treatment of metastatic carcinoma 2008 ·Journal of Clinical Oncology ·(unknown), Jean‐Philippe Spano, Joël S. Bloch, Roger Mouawad, Jean‐Marc Foult, (unknown), C. Soubrane, D. Buthiau, D. Khayat	1
15	Safety and pharmacokinetics of intravenous VEGF Trap plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in a combination phase I clinical trial of patients with advanced solid tumors 2006 ·Journal of Clinical Oncology ·O. Rixe, Chris Verslype, (unknown), Sabine Tejpar, Joël S. Bloch, (unknown), D. Khayat, Eric S. Furfine, Sylvie Assadourian, Eric Van Cutsem	12
16	Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy 2005 ·Current Medical Research and Opinion ·Joël S. Bloch, Olivier Rixe, Jean‐Baptiste Méric, Andrew Delgado, D. Khayat	10
17	Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck 2004 ·European Journal of Cancer ·Florence Duffaud, Markus Borner, P. Chollet, J. B. Vermorken, Joël S. Bloch, M. Degardin, F. Rolland, Christian Dittrich, B. Barón, Didier Lacombe, P. Fumoleau	30
18	New imaging techniques in oncology 2003 ·European Journal of Cancer Supplements ·D. Buthiau, Olivier Rixe, (unknown), (unknown), Miguel Delgado‐Rodríguez, Marwin Gutiérrez, Joël S. Bloch, Peter Bloch, (unknown), D. Khayat	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact